In this context, inflation is set to remain low. In Switzerland, the inflation rate has been negative since last spring, below the 0-2% range by which the SNB defines its price stability objective. Moreover, in the two-month period October-November it was below the projection published by the SNB in September. It is therefore likely that the central bank will revise down the inflation outlook.
The persistence of very low inflation is a strong reason for the SNB to increase the monetary policy accommodation. However, the SNB has exhausted the room for manoeuvre on interest rates, which will be confirmed at -0.75% at the SNB meeting today. Interventions on the foreign exchange market to counter the appreciation of the Swiss franc and to reduce the risk of deflation will remain a key part of SNB's monetary policy.
However, many commentators fear the central bank may be less determined in its currency intervention after US Treasury designated Switzerland a currency manipulator on December 16th. But this should not and, we think, will not, be the case because, simply said, Switzerland is not actually a currency manipulator.
While, Switzerland met the three quantitative criteria set by the US Treasury, that did not happen as a result of keeping the exchange rate low and gaining an unfair competitive advantage. The three criteria set by the US treasure are:
- a bilateral trade surplus with the US of more than USD 20bn;
- a current account surplus of more than 2% of GDP;
- persistent one-sided currency intervention, adding to 2% of GDP over the last six to 12 months.
Switzerland had a bilateral trade surplus of USD29bn with the US in the 12 months to October (see Chart 2). However, the growth in Switzerland's bilateral surplus is mainly due to the export of pharmaceutical goods, a sector in which Switzerland is among the world's leaders and which is meeting growing US demand, also linked to the ageing of its population.1